NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES)
BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES)

NCT04823663

RecruitingN/A

Sponsor: Boston Scientific Corporation

Conditions: Cardiac Disease

Interventions: Implant, Electrophysiologic procedure

Countries: Belgium, Canada, France, Germany, Greece, Ireland, Israel, Italy

SOCRATES is part of Boston Scientific's (BSC) Post-market surveillance system. The implementation of such systems is mandatory per local regulations such as the Regulation '(EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices' or short Medical Device Regulation (MDR). The SOCRATES design is therefore based on the BSC's commitment as well as external regulatory requirements to proactively and systematically gather, record and analyze relevant data on the quality, performance and safety of devices throughout their entire lifetime.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

1. Subject is willing and capable of providing informed consent and/or to give approval to collect/store/process personal health information by the sponsor or such consent/approval is provided by a legally designated representative, if required by local law or regulation.
2. Subject is (one criterion must be fulfilled) a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii. the BSC CRM product implant.

Exclusion Criteria:

1. Subject is foreseen not to be followed at the enrolling center for at least 1 year after an implant procedure (CRM) or at least 1 month (EP).
2. Subject is receiving diagnosis or therapy by means of any product, that is not approved for commercial use at the time of implant/procedure.
Locations (26)
  • Jette, Belgium
  • Yvoir, Belgium
  • Québec, Quebec, Canada
  • Brest, France
  • Clermont-Ferrand, France
  • Lomme, France
  • Pau, France
  • Saint-Etienne, France
  • Berlin, Germany
  • Bochum, Germany
  • Athens, Greece
  • Athens, Greece
  • Dublin, Ireland
  • Ramat Gan, Israel
  • Tel Aviv, Israel
  • Tel Aviv, Israel
  • Modena, Italy
  • Roma, Italy
  • Roma, Italy
  • Roma, Italy
  • Madrid, Spain
  • San Cristóbal de La Laguna, Spain
  • Santa Cruz de Tenerife, Spain
  • Zaragoza, Spain
  • London, United Kingdom
  • Manchester, United Kingdom